Fundraising Fox

Certara

NASDAQ: CERT

Radnor, US · Founded 2017 · Delaware corporation · 1 known investors

BiotechHealthtech

Founders & leadership

JG
John Gallagher IIISVP and Chief Financial Officer
AM
Adrian McKemeyPresident, Certara Drug Development Solutions
RA
Rona AnhaltChief Human Resources Officer
CC
Cynthia CollinsDirector
DC
Daniel CorcoranSVP and General Counsel
JR
John ReyndersDirector
SM
Stephen McLeanDirector
MW
Matthew WalshDirector
RA
Robert AspburyPresident, Certara Predicitive Technologies
EB
Eran BroshyDirector
LP
Leif PedersenPresident, Chief Commercial Officer
WF
William FeeheryCEO and Director

Investors · 1

Iaso VenturesreportedCambridgevia John Reynders · board

Reported raises · per SEC filings

Form D private placements
▶$8.6MraisedApr 2026 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Rona AnhaltExecutive Officer
  • Cynthia CollinsDirector
  • Eran BroshyDirector
  • Matthew WalshDirector
  • Stephen McLeanDirector
  • James CashmanDirector
  • David SpaightDirector
  • John Gallagher IIIExecutive Officer
  • Nancy KilleferDirector
  • Daniel CorcoranExecutive Officer
  • Arjun BediDirector
  • Rosemary CraneDirector
  • Robert AspburyExecutive Officer
  • John ReyndersDirector
  • Leif PedersenExecutive Officer
  • Adrian McKemeyExecutive Officer
  • Jon ResnickExecutive Officer, Director
Amount sold
$8.6M
First sale
Apr 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.7MraisedMar 2025 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • John Gallagher IIIExecutive Officer
  • Adrian McKemeyExecutive Officer
  • Rona AnhaltExecutive Officer
  • Cynthia CollinsDirector
  • Daniel CorcoranExecutive Officer
  • John ReyndersDirector
  • Stephen McLeanDirector
  • Matthew WalshDirector
  • Robert AspburyExecutive Officer
  • Eran BroshyDirector
  • Leif PedersenExecutive Officer
  • William FeeheryExecutive Officer, Director
  • David SpaightDirector
  • Rosemary CraneDirector
  • James CashmanDirector
  • Nancy KilleferDirector
Amount sold
$5.7M
First sale
Mar 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedMar 2024 · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Cynthia CollinsDirector
  • Patrick SmithExecutive Officer
  • Rosemary CraneDirector
  • Nancy KilleferDirector
  • Nicolette ShermanExecutive Officer
  • Eran BroshyDirector
  • Matthew WalshDirector
  • Stephen McLeanDirector
  • John Gallagher IIIExecutive Officer
  • Robert AspburyExecutive Officer
  • David SpaightDirector
  • William FeeheryExecutive Officer, Director
  • Leif PedersenExecutive Officer
  • James Cashman IIIDirector
  • Richard TraynorExecutive Officer
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedSep 2021 · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jieun W. ChoeExecutive Officer
  • Richard M. TraynorExecutive Officer
  • Craig R. RaynerExecutive Officer
  • Nancy KilleferDirector
  • Carol G. GallagherDirector
  • Eric C. LiuDirector
  • Robert AspburyExecutive Officer
  • Justin EdgeExecutive Officer
  • Leif E. PedersenExecutive Officer
  • Ethan WaxmanDirector
  • Nicolette D. ShermanExecutive Officer
  • Cynthia CollinsDirector
  • Michael Andrew SchemickExecutive Officer
  • Sherilyn S. McCoyExecutive Officer
  • Mason P. SlaineDirector
  • Matthew WalshDirector
  • James E. Cashman IIIDirector
  • Stephen M. McLeanDirector
  • William F. FeeheryExecutive Officer, Director
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.